A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis
Clinical trial NCT05238675 · COMPLETED
Trial details
- NCT number
- NCT05238675
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-28
- Primary completion
- 2024-05-01
- Enrollment
- 322
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.